Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers
Status:
Withdrawn
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and United States of America (USA). The aim of this trial
is to examine the bioequivalence (assessment of the expected biological equivalence of two
pharmaceutical drug products with identical active ingredient) of Norditropin® versus
Nutropin AQ® in healthy adult volunteers.